| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Leukocyte Biology Section, Division of Biomedical Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom; and
Division of Genomic Medicine, University of Sheffield, Royal Hallamshire Hospital, Sheffield, United Kingdom
We previously showed in a small group of donors that eosinophils from a subgroup of individuals responded equipotently to CC chemokine ligand (CCL)11/eotaxin and CCL3/macrophage-inflammatory protein-1
in assays of eosinophil shape change (CCL3/macrophage-inflammatory protein-1-highly responsive (MHR) donors). In this study, we investigated the functional role of CCL3 in eosinophil responses in 73 donors. MHR donors, identified by their eosinophil shape change responses, represented 
19% of the donor pool. Eosinophils from these donors showed increased eosinophil CCR1 expression and also underwent CCL3-mediated chemotaxis and up-regulation of CD11b. All MHR donors gave a history of atopy-associated diseases. In a further study, we prospectively recruited 110 subjects, subdivided into nonatopics or atopics, and investigated expression of CCR1 and CCR3 on eosinophils, basophils, monocytes, and neutrophils. Eosinophil CCR1 expression was non-normally distributed in atopics, although higher CCR1 expression levels were not predictive of a diagnosis of atopy or atopic disease. We identified the CCR1 promoter and investigated its function. We found a minimal promoter within 177 bp of the transcription start site, and an upstream enhancer region that facilitated expression in leukocyte cell lines. Collectively, these data demonstrate that MHR individuals form an important subgroup that, when associated with a diagnosis of allergic disease, may require tailored therapy to modulate eosinophil recruitment. Identification of a functional CCR1 promoter will facilitate the study of possible genetic determinants underlying this potentially important clinical phenotype.
This article has been cited by other articles:
|
|
 |
|
  K J Mackerness, G R Jenkins, A Bush, and P J Jose Characterisation of the range of neutrophil stimulating mediators in cystic fibrosis sputum Thorax, July 1, 2008; 63(7): 614 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Joubert, S. Lajoie-Kadoch, M. Welman, S. Dragon, S. Letuvee, B. Tolloczko, A. J. Halayko, A. S. Gounni, K. Maghni, and Q. Hamid Expression and Regulation of CCR1 by Airway Smooth Muscle Cells in Asthma J. Immunol., January 15, 2008; 180(2): 1268 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Wise, C. Duchesnes, P. C. A. da Fonseca, R. A. Allen, T. J. Williams, and J. E. Pease Small Molecule Receptor Agonists and Antagonists of CCR3 Provide Insight into Mechanisms of Chemokine Receptor Activation J. Biol. Chem., September 21, 2007; 282(38): 27935 - 27943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gupta, S. Schulz-Maronde, C. Kutzleb, R. Richter, W.-G. Forssmann, A. Kapp, U. Forssmann, and J. Elsner Cloning, expression, and functional characterization of cynomolgus monkey (Macaca fascicularis) CC chemokine receptor 1 J. Leukoc. Biol., November 1, 2005; 78(5): 1175 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. L. de Mendonca, P. C. A. da Fonseca, R. M. Phillips, J. W. Saldanha, T. J. Williams, and J. E. Pease Site-directed Mutagenesis of CC Chemokine Receptor 1 Reveals the Mechanism of Action of UCB 35625, a Small Molecule Chemokine Receptor Antagonist J. Biol. Chem., February 11, 2005; 280(6): 4808 - 4816. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
